Jochen G.
- Country
- Germany
- Department
- Medizinische Klinik
Research Overview
- A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE-158)
- Phase III Randomized, Placebo-Controlled Study of Venetoclax with Induction and Consolidation Chemotherapy in Newly Diagnosed AML or MDS-EB2 Patients
- Phase III Evaluation of Elotuzumab with Carfilzomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Post-Autologous Stem Cell Transplant
Data & Insights
Has run more than one trial at 148 of 322 partner sites.
Specializations
Hematologic Malignancies
The investigator specializes in treating various forms of blood cancers, with particular emphasis on multiple myeloma and different types of lymphoma.
- Multiple Myeloma Treatment Innovation
- Diffuse Large B-cell Lymphoma Management
- Hodgkin Lymphoma Therapy
Areas of focus include novel therapeutic combinations and maintenance strategies post stem cell transplantation.
Leukemia Studies
Expertise in treating various forms of acute leukemia, including both lymphoblastic and myeloid variants.
- Philadelphia-Chromosome Positive ALL
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
Special interest in targeted therapies and innovative treatment approaches for leukemia patients.
Solid Tumor Research
Experience in investigating advanced solid tumors across multiple cancer types.
- Gastrointestinal Malignancies
- Gynecologic Cancers
- Thoracic Cancers
Focus on immunotherapy approaches and biomarker-driven treatment strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.